Mesylate based master mix

US11293059B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11293059-B2
Application numberUS-201816623975-A
CountryUS
Kind codeB2
Filing dateJun 20, 2018
Priority dateJun 22, 2017
Publication dateApr 5, 2022
Grant dateApr 5, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are mesylate containing compositions, methods of use of such compositions and kits of components encompassing such compositions for improving the amplification of nucleic acids, especially in the presence of enzymatic inhibitors. These find particular use in forensic and environmental analyses. The instant disclosure provides new compositions, methods and kits of components for overcoming PCR inhibition. In some embodiments disclosed herein is a PCR master mix, the PCR master mix encompassing a mesylate.

First claim

Opening claim text (preview).

We claim: 1. A PCR master mix comprising: Tris-mesylate at a concentration of 10-50 mM; potassium methanesulfonate at a concentration of 30-80 mM; bovine serum albumin at a concentration of 1.2-4 mg/ml; and glycerol at a concentration of 3-8% by volume. 2. The PCR master mix of claim 1 , further comprising deoxynucleoside triphosphate. 3. The PCR master mix of claim 1 , further comprising a DNA polymerase. 4. The PCR master mix of claim 1 , further comprising a deoxynucleoside triphosphate, a non-ionic detergent and a DNA polymerase. 5. A kit comprising a first capped tube comprising a PCR master mix as in claim 1 , and a second capped tube comprising a primer. 6. The kit of claim 5 , wherein the master mix further comprises a polymerase. 7. The kit of claim 6 , further comprising a third capped tube comprising an allelic ladder. 8. A method, the method comprising contacting a sample with a PCR master mix and thereby forming a contacted sample, the PCR master mix comprising Tris-mesylate (10-50 mM), potassium methanesulfonate (30-80 mM), bovine serum albumin (1.2-4 mg/ml), glycerol (3-8% volume), MgSO4 (1.4-2.4 mM), Sodium Azide (0.01-0.04%), dATP, dCTP, dGTP, dTTP, at least two primers and a DNA polymerase, subjecting the contacted sample to a thermocycling protocol, thereby forming a cycled sample and subjecting the cycled sample to an electrophoretic separation and thereby detecting a presence or absence of an amplicon. 9. A PCR master mix comprising one or more of: Tris-mesylate at a concentration of 10-50 mM, potassium methanesulfonate at a concentration of 30-80 mM, or magnesium methanesulfonate at a concentration of 1.2-1.8 mM, the PCR master mix further comprising a stabilizer compound, wherein the stabilizer compound comprises glycerol at a concentration of 3-8% by volume. 10. The PCR master mix of claim 9 , further comprising a proteinaceous compound. 11. The PCR master mix of claim 10 , wherein the proteinaceous compound is bovine serum albumin. 12. The PCR master mix of claim 11 , wherein the bovine serum albumin is provided at a concentration of 1.2-4 mg/ml. 13. The PCR master mix of claim 9 , further comprising deoxynucleoside triphosphate. 14. The PCR master mix of claim 9 , further comprising a DNA polymerase. 15. A PCR master mix comprising one or more of: Tris-mesylate at a concentration of 10-50 mM, potassium methanesulfonate at a concentration of 30-80 mM, or magnesium methanesulfonate at a concentration of 1.2-1.8 mM, the PCR master mix further comprising a proteinaceous compound, wherein the proteinaceous compound is bovine serum albumin. 16. The PCR master mix of claim 15 , further comprising a stabilizer compound. 17. The PCR master mix of claim 16 , wherein the stabilizer compound comprises glycerol or sucrose. 18. The PCR master mix of claim 15 , wherein the bovine serum albumin is provided at a concentration of 1.2-4 mg/ml. 19. The PCR master mix of claim 15 , further comprising deoxynucleoside triphosphate. 20. The PCR master mix of claim 15 , further comprising a DNA polymerase. 21. A PCR master mix comprising one or more of: Tris-mesylate at a concentration of 10-50 mM, potassium methanesulfonate at a concentration of 30-80 mM, or magnesium methanesulfonate at a concentration of 1.2-1.8 mM, the PCR master mix further comprising deoxynucleoside triphosphate. 22. The PCR master mix of claim 21 , further comprising a stabilizer compound. 23. The PCR master mix of claim 22 , wherein the stabilizer compound comprises glycerol or sucrose. 24. The PCR master mix of claim 21 , further comprising a proteinaceous compound. 25. The PCR master mix of claim 24 , wherein the proteinaceous compound is bovine serum albumin and wherein the bovine serum albumin is provided at a concentration of 1.2-4 mg/ml. 26. The PCR master mix of claim 21 , further comprising a DNA polymerase. 27. A PCR master mix comprising one or more of: Tris-mesylate at a concentration of 10-50 mM, potassium methanesulfonate at a concentration of 30-80 mM, or magnesium methanesulfonate at a concentration of 1.2-1.8 mM, the PCR master mix further comprising a DNA polymerase. 28. The PCR master mix of claim 27 , further comprising a stabilizer compound. 29. The PCR master mix of claim 28 , wherein the stabilizer compound comprises glycerol or sucrose. 30. The PCR master mix of claim 27 , further comprising a proteinaceous compound. 31. The PCR master mix of claim 30 , wherein the proteinaceous compound is bovine serum albumin, and wherein the bovine serum albumin is provided at a concentration of 1.2-4 mg/ml.

Assignees

Inventors

Classifications

  • characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title

  • Specific component of sample, medium or buffer · CPC title

  • C12Q1/686Primary

    Polymerase chain reaction [PCR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11293059B2 cover?
Disclosed herein are mesylate containing compositions, methods of use of such compositions and kits of components encompassing such compositions for improving the amplification of nucleic acids, especially in the presence of enzymatic inhibitors. These find particular use in forensic and environmental analyses. The instant disclosure provides new compositions, methods and kits of components for…
Who is the assignee on this patent?
Life Technologies Corp
What technology area does this patent fall under?
Primary CPC classification C12Q1/686. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).